Comparing Leucovorin vs Levoleucovorin
Leucovorin | Levoleucovorin |
|
---|
Leucovorin | Levoleucovorin |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Methotrexate Overdosage, Folic Acid Antagonist Overdose, Colorectal Cancer, Anemia - Megaloblastic, Methotrexate Rescue, Pneumocystis Pneumonia, Pneumocystis Pneumonia Prophylaxis... View more |
Prescription only
Prescribed for Colorectal Cancer, Methotrexate Overdosage, Methotrexate Rescue. Levoleucovorin may also be used for purposes not listed in this medication guide. |
Related suggestions Colorectal Cancer
Methotrexate Overdosage
|
|||||||||||||||
More about Leucovorin | More about Levoleucovorin | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Leucovorin side effects |
View all Levoleucovorin side effects |
||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
Lower cost generic |
Lower cost generic |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Leucovorin prices |
View all Levoleucovorin prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
Wellcovorin | Fusilev, Khapzory | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
1 hour |
6.8 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 28 drugs are known to interact with Leucovorin:
|
A total of 25 drugs are known to interact with Levoleucovorin:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
February 08, 1980 |
N/A |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Khapzory
Khapzory is used for colorectal cancer, methotrexate overdosage, methotrexate rescue
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Platinol
Platinol is used for bladder cancer, blood cell transplantation, bone marrow transplantation, brain ...
Zynyz
Zynyz is a targeted cancer treatment used to squamous cell carcinoma of the anal canal (SCAC) and ...
Mutamycin
Mutamycin is used for bladder cancer, pancreatic cancer, stomach cancer
Adrucil
Adrucil is used for breast cancer, breast cancer, palliative, cancer, colorectal cancer, pancreatic ...
Zusduri
Zusduri is used to treat recurrent low-grade, intermediate-risk, non-muscle invasive bladder cancer ...
Retifanlimab
Retifanlimab is used for anal cancer, merkel cell carcinoma
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.